Andere Sprachen TecDAX

Index

Verzögert Xetra 08:50:00 06.12.2024			% 5 Tage	% 1. Jan.
3’515.46 ^PTS	+0.05%		+2.75%	+5.33%

06:20	ÜBERBLICK/Anstehende Indexänderungen zum 23. Dezember	DJ
05.12.	ÜBERBLICK/Anstehende Indexänderungen zum 23. Dezember	DJ

Nachrichten in anderen Sprachen zu TecDAX

MorphoSys AG(XTRA:MOR) dropped from Germany TECDAX (Total Return) Index	24.06.
MorphoSys to Leave Deutsche Börse’s MDAX, TecDAX Indices	19.06.
Deutsche Börse's Stoxx to Make Changes to DAX Indices	06.03.
Indexen: Brazilië en tech in de schijnwerpers in november	28.11.
Indici: Brasile e tecnologia in primo piano a novembre	28.11.
Indices: Focus on tech, Brazil and China	27.11.
Índices: Brasil, China y las tecnológicas, protagonistas en noviembre	27.11.
Indices : le Brésil et la tech à l'honneur en novembre	27.11.
Deutsche Börse Shuffles DAX Index Composition	06.09.23
Indici: il DAX mantiene le distanze dal resto della famiglia	17.08.23
Indexen: de DAX houdt de rest van de familie op afstand	17.08.23
Índices: El DAX mantiene a raya al resto de su familia	16.08.23
Indices : le DAX garde le reste de sa famille à distance	16.08.23
Software AG Takeover Spurs Changes in Three German Indices	21.07.23
Europe Information Technology ETF Market Shows Positive Performance with 1.71% Gain	29.06.23
Nordex mantiene su previsión tras los problemas de Siemens Gamesa, sube en bolsa	27.06.23
Global markets live: Airbus, Intel, Meta Platforms, Berkshire Hathaway...	19.06.23
EN DIRECTO DESDE LOS MERCADOS: Airbus, Sartorius, Roche, Stedim Biotech, Meta, Teleperformance, Intel, Berkshire...	19.06.23
Bolsa de Madrid: ¿Harto de los bancos centrales? ¡Qué pena!	19.06.23
Marre des banques centrales ? Dommage !	19.06.23
En Direct des Marchés : Airbus, Sartorius Stedim Biotech, Michelin, Teleperformance, Casino, Intel, Berkshire...	19.06.23
Deutsche Börse Shuffles DAX Index Composition	06.06.23
Deutsche Börse Removes Vantage Towers from Stoxx Indices Over Listing Rule Violation	08.05.23
Deutsche Börse Deletes Evotec, SMA Solar Technology from Indices Over Annual Report Rule	05.05.23
Borsa: Asia in rialzo, Covid non fa più paura	02.11.22
Infranity nomme Patrick Liedtke chef économiste & chief client officer	27.09.22
Ferroviaire: la SNCF et DWS vont céder le loueur de locomotives Akiem	01.08.22
DGAP-Adhoc : Siltronic raises forecast for financial year 2021	20.04.21
PRESS RELEASE : Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse	20.04.21
PRESS RELEASE : MorphoSys and Incyte Announce -2-	19.04.21
PRESS RELEASE : MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory FL or MZL	19.04.21
DGAP-Adhoc : Carl Zeiss Meditec AG returns to significant revenue growth in second quarter 2020/21	19.04.21
PRESS RELEASE : Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801	19.04.21
PRESS RELEASE : 1&1 Drillisch Aktiengesellschaft: Changing Our Name from 1&1 Drillisch AG to 1&1 AG	15.04.21
PRESS RELEASE : Universitätsklinik Hamburg-Eppendorf (UKE) decides for a future with CGM CLINICAL	15.04.21
PRESS RELEASE : ???????Nordex Group reports order intake of 1.2 gigawatts in the first quarter of 2021	15.04.21
PRESS RELEASE : TeamViewer AG: TeamViewer appoints Lisa Agona as CMO and management board member	15.04.21
PRESS RELEASE : ???????Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin	14.04.21
PRESS RELEASE : Nordex SE: Nordex Group receives order for 97 MW from wpd in Finland	14.04.21
DGAP-Adhoc : SAP SE: SAP Announces Preliminary -2-	13.04.21
PRESS RELEASE : Evotec launches 'beLAB2122', -2-	13.04.21
PRESS RELEASE : Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb	13.04.21
PRESS RELEASE : Nordex SE: The Nordex Group supplies the VSB Group with turbines totalling 42 MW to Poland	13.04.21
DGAP-Adhoc : Eckert & Ziegler Receives Technetium Generator Licenses for Brazil	12.04.21
PRESS RELEASE : Evotec and Exscientia announce start of human clinical trials of novel immuno-oncology drug	09.04.21